Source / episode info

• **Episode:**614
• **Title:**DIP Ep 614: USMLE Step 2/3 Rapid Review Series 126 (Basic Sciences)
• **Published:**2025-07-18
• Source:Episode page

One-liner

Episode 614 is a rapid review emphasizing the management of thyroid storm via peripheral deiodinase inhibition and beta-blockade, alongside high-yield molecular concepts in connective tissue disorders (collagenopathies) and extracellular matrix proteins (elastin/fibrillin).

High-yield summary

• Thyroid Storm: The hallmark finding is an undetectable TSH combined with severe hypermetabolic state. First-line treatment involves IV lipid-soluble beta-blockers to mitigate the effects of excessive _1 receptor stimulation on cardiomyocytes.
• Peripheral Deiodinase Inhibition: Both high doses of beta-blockers and antithyroid drugs like Propylthiouracil (PTU) reduce T3 levels by inhibiting peripheral conversion of T4 to T3, which is the most metabolically active hormone.
• Collagenopathies Differentiation: Must distinguish between specific collagen defects: Goodpasture Syndrome (_3 chain of Type IV); Outpourred Syndrome (_5 chain of Type IV); and Osteogenesis Imperfecta (Type I).
• Scurvy Mechanism: Vitamin C is a critical cofactor for the hydroxylation of proline and lysine residues in collagen, making impaired synthesis due to deficiency a key board concept.
• ECM Degradation: Increased protease activity (e.g., from smoking/inflammation) degrades elastin, leading to increased lung compliance; conversely, antitrypsin deficiency impairs this protective mechanism.

Learning objectives

• Describe the pathophysiology and initial management of thyroid storm using peripheral deiodinase inhibition.
• Differentiate between various collagenopathies based on the specific defective collagen chain (\alpha_3 vs \alpha_5 vs Type I).
• Explain the role of Vitamin C as a cofactor in stabilizing collagen structure via hydroxylation.
• Identify the molecular basis for increased lung compliance in chronic obstructive pulmonary disease (COPD).
• Recognize the clinical manifestations associated with deficiencies in major extracellular matrix proteins (e.g., Elastin, Fibrillin).

Board exam buzzwords